Effect-site concentration of propofol required for LMA-Supreme™ insertion with and without remifentanil: a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s12871-015-0115-8
Published Online: 2015-10-06
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zaballos, Matilde
Bastida, Emilia
Agustí, Salomé
Portas, Maite
Jiménez, Consuelo
López-Gil, Maite
License valid from 2015-10-06